Chung Hoow Kok

25PUBLICATIONS

89CO-AUTHORS

Cancer cell biologyPredictive and prognostic markersGenomicsHaematological tumoursRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 11, 2026

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.

|May 18, 2026

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

|Jan 01, 2026

Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice.

Loretta Dorstyn, Yoon Lim, Jack Scanlan

|Nov 17, 2025

Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis.

Yasir Kusay, Denghao Wu, Sunita Mc De Sousa

|Sep 02, 2025

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Naranie Shanmuganathan, David T Yeung, Carol Wadham

|May 22, 2025

RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

Pageof 5

Frequent Collaborators

Mithun Vinod Shah

Devendra K Hiwase

Hamish Scott

Christopher N Hahn

Mrinal Patnaik

Anna L Brown

Timothy P Hughes

Kevin Hung

Naseema Gangat

Anmol Baranwal

Frequent Collaborators

Mithun Vinod Shah

Devendra K Hiwase

Hamish Scott

Christopher N Hahn